Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Large Language Models in Oncology: Revolution or Cause for Concern?
Caglayan A, Slusarczyk W, Rabbani RD, Ghose A, Papadopoulos V, Boussios S. Caglayan A, et al. Among authors: ghose a. Curr Oncol. 2024 Mar 29;31(4):1817-1830. doi: 10.3390/curroncol31040137. Curr Oncol. 2024. PMID: 38668040 Free PMC article. Review.
The integration of palliative care with oncology: the path ahead.
Caglayan A, Redmond S, Rai S, Rabbani RD, Ghose A, Sanchez E, Sheriff M, Carrim J, Boussios S. Caglayan A, et al. Among authors: ghose a. Ann Palliat Med. 2023 Nov;12(6):1373-1381. doi: 10.21037/apm-22-1154. Epub 2023 Oct 11. Ann Palliat Med. 2023. PMID: 37872127 Free article. Review.
Gestational Renal Cell Cancer - An Update.
Caglayan A, Rabbani RD, Sanchez E, Choi S, Ismail A, Papadopoulos V, Adeleke S, Ghose A, Boussios S. Caglayan A, et al. Among authors: ghose a. Anticancer Res. 2023 Sep;43(9):3871-3880. doi: 10.21873/anticanres.16574. Anticancer Res. 2023. PMID: 37648307 Review.
Re: Pain and Health-related Quality of Life with Olaparib Versus Physician's Choice of Next-generation Hormonal Drug in Patients with Metastatic Castration-resistant Prostate Cancer with Homologous Recombination Repair Gene Alterations (PROfound): An Open-label, Randomised, Phase 3 Trial.
Adeleke S, Ghose A, Boussios S. Adeleke S, et al. Among authors: ghose a. Eur Urol. 2023 Aug;84(2):246-247. doi: 10.1016/j.eururo.2023.03.023. Epub 2023 Apr 7. Eur Urol. 2023. PMID: 37032188 Clinical Trial. No abstract available.
Renal Cell Cancer - Insights in Drug Resistance Mechanisms.
Aweys H, Lewis D, Sheriff M, Rabbani RD, Lapitan P, Sanchez E, Papadopoulos V, Ghose A, Boussios S. Aweys H, et al. Among authors: ghose a. Anticancer Res. 2023 Nov;43(11):4781-4792. doi: 10.21873/anticanres.16675. Anticancer Res. 2023. PMID: 37909991 Review.
Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum.
Carter L, Apte V, Shukla A, Ghose A, Mamidi R, Petohazi A, Makker S, Banerjee S, Boussios S, Banna GL. Carter L, et al. Among authors: ghose a. Curr Oncol Rep. 2024 Jan;26(1):65-79. doi: 10.1007/s11912-023-01486-2. Epub 2024 Jan 2. Curr Oncol Rep. 2024. PMID: 38180692 Free PMC article. Review.
Exosomes in the Diagnosis and Treatment of Renal Cell Cancer.
Boussios S, Devo P, Goodall ICA, Sirlantzis K, Ghose A, Shinde SD, Papadopoulos V, Sanchez E, Rassy E, Ovsepian SV. Boussios S, et al. Among authors: ghose a. Int J Mol Sci. 2023 Sep 20;24(18):14356. doi: 10.3390/ijms241814356. Int J Mol Sci. 2023. PMID: 37762660 Free PMC article. Review.
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape.
Ghose A, Lapitan P, Apte V, Ghosh A, Kandala A, Basu S, Parkes J, Shinde SD, Boussios S, Sharma A, Das P, Vasdev N, Rebuzzi SE, Ürün Y, Kanesvaran R, Maniam A, Banna GL. Ghose A, et al. Curr Oncol Rep. 2024 Apr 23. doi: 10.1007/s11912-024-01524-7. Online ahead of print. Curr Oncol Rep. 2024. PMID: 38652426 Review.
415 results